Bayer’s Lynkuet (elinzanetant) has received FDA approval to treat moderate to severe vasomotor symptoms including hot flashes and night sweats, during menopause.

🔍 Explore the clinical evidence for Lynkuet at DRUGDOCS® drugdocs.com/drug/Lynkuet

#FDA #PharmaUpdate #MenopauseTreatment #DrugDocs

Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results
#PfizerEarnings #PharmaUpdate #DrugPricingDebate
www.youtube.com/watch?v=lSmR...